Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMJIH83)

Drug Name	XmAb20717 DMJIH83
Synonyms	XmAb717
Drug Type	Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Melanoma	DIS1RRCY	2C30	Phase 1	[2]
Breast cancer	DIS7DPX1	2C60-2C65	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.J Med Chem. 2019 Feb 28;62(4):1715-1730.
2	ClinicalTrials.gov (NCT03517488) A Study of XmAb20717 in Subjects With Selected Advanced Solid Tumors (DUET-2). U.S. National Institutes of Health.